Distribution of the beta 1 subgroup of the integrins in human cells and tissues

We studied the distribution of the beta 1 integrin subfamily in human tissues and cells by light microscopy, electron microscopy, and immunoblotting, using monoclonal antibody DH12, previously shown to react with the beta 1 subunit of the human fibronectin receptor. Crossreaction with the other beta...

Full description

Saved in:
Bibliographic Details
Published inThe journal of histochemistry and cytochemistry Vol. 37; no. 3; pp. 299 - 307
Main Authors De Strooper, B, Van der Schueren, B, Jaspers, M, Saison, M, Spaepen, M, Van Leuven, F, Van den Berghe, H, Cassiman, JJ
Format Journal Article
LanguageEnglish
Published Los Angeles, CA Histochemical Soc 01.03.1989
SAGE Publications
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We studied the distribution of the beta 1 integrin subfamily in human tissues and cells by light microscopy, electron microscopy, and immunoblotting, using monoclonal antibody DH12, previously shown to react with the beta 1 subunit of the human fibronectin receptor. Crossreaction with the other beta subunits of the integrin family, which have 45% and 47% primary amino acid sequence identity with the beta 1 subunit, was excluded, as MAb DH12 did not react with the beta 2 subunit in granulocytes and the beta 3 subunit in thrombocytes. Reactivity with the anti-beta 1 antibody was found in skin, lung, heart, striated and smooth muscle, blood cells, liver, kidney, intestine, spleen and placenta. Thus, cells of mesodermal, ectodermal, and entodermal origin express the beta 1 subunit. In skin fibroblasts cultured in vitro, beta 1 subunit was also detected intracellularly. The wide distribution of the beta 1 family, originally detected in activated T-lymphocytes after prolonged culture in vitro, contrast with the restricted distribution of the beta 2 integrins on leucocytes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-1554
1551-5044
DOI:10.1177/37.3.2645360